Dementia Care Mapping and Patient-Centred Care in Australian residential homes: An economic evaluation of the CARE Study, CHERE Working Paper 2008/4



Figure 2: Adjusted Cohen Mansfield Agitation Inventory score by treatment
group and time (higher scores indicate greater agitation)

CMAI


—♦— DCM

—•— PCC

—UC UC


Table 2: Annual Pharmaceutical Costs Per Resident

Mean, standard
deviation

DCM

PCC

UC

Total

Period

Pre-

Intervention

598.44

(906.30)

647.35

(790.39)

473.25

(905.64)

579.51

(868.34)

Post-

Intervention

617.72

(955.06)

597.89

(852.35)

363.00

(852.75)

541.45

(897.13)

Follow-up

542.21

(883.32)

560.49

(823.68)

398.19

(871.16)

508.10

(860.10)

Total

587.31

(913.29)

605.37

(818.91)

414.96

(875.68)

545.55

(874.88)

Pair-wise t-tests were run on this information, investigating whether the
pharmaceutical costs per person at a time point were statistically significantly
different from the observed mean. In the nine pair-wise comparisons, none were
statistically significant at the 5% level. Therefore, as the mean difference between



More intriguing information

1. The name is absent
2. NATIONAL PERSPECTIVE
3. A Pure Test for the Elasticity of Yield Spreads
4. The Role of Evidence in Establishing Trust in Repositories
5. ISO 9000 -- A MARKETING TOOL FOR U.S. AGRIBUSINESS
6. Benchmarking Regional Innovation: A Comparison of Bavaria, Northern Ireland and the Republic of Ireland
7. Distortions in a multi-level co-financing system: the case of the agri-environmental programme of Saxony-Anhalt
8. Crime as a Social Cost of Poverty and Inequality: A Review Focusing on Developing Countries
9. Initial Public Offerings and Venture Capital in Germany
10. Natural Resources: Curse or Blessing?